Alere (NYSE:ALR) said it recalled several of its blood clot-testing products over concerns they might provide inaccurate results that could result in serious injury or death.
According to the FDA's website, Alere issued a recall Dec. 5 for its INRatio and INRatio2 monitors and test strips after receiving reports the devices failed to accurately measure a patient's international normalized ratio, or INR. The products are used to determine the blood-clotting speed, or prothrombin time, in patients taking the anticoagulant drug warfarin.
Help employers find you! Check out all the jobs and post your resume.
According to the FDA's website, Alere issued a recall Dec. 5 for its INRatio and INRatio2 monitors and test strips after receiving reports the devices failed to accurately measure a patient's international normalized ratio, or INR. The products are used to determine the blood-clotting speed, or prothrombin time, in patients taking the anticoagulant drug warfarin.
Help employers find you! Check out all the jobs and post your resume.
